AnaptysBio
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $43,113 | $30,017 | $10,971 | $7,179 |
Gross Profit | 43,113 | 29,421 | 10,376 | 6,574 |
EBITDA | -3,785 | -16,842 | -35,103 | -37,014 |
EBIT | -4,386 | -17,438 | -35,698 | -37,619 |
Net Income | -21,784 | -32,851 | -46,660 | -43,936 |
Net Change In Cash | 43,113 | 30,017 | 10,971 | 7,179 |
Free Cash Flow | -66,935 | -10,125 | -14,415 | -44,220 |
Cash | 123,080 | 191,581 | 71,821 | 53,695 |
Basic Shares | 28,382 | 28,893 | 27,356 | 26,801 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $91,280 | $17,157 | $10,287 | $63,175 |
Gross Profit | 91,280 | 14,781 | 7,952 | -35,321 |
EBITDA | -92,744 | -143,164 | -105,257 | -55,706 |
EBIT | -95,141 | -145,540 | -107,592 | -57,795 |
Net Income | -145,231 | -163,619 | -128,724 | -57,193 |
Net Change In Cash | 91,280 | 17,157 | 10,287 | 63,175 |
Cost of Revenue | -424,421 | 245,213 | ||
Free Cash Flow | -135,695 | -121,607 | -73,951 | -47,286 |
Cash | 123,080 | 35,965 | 71,308 | 495,729 |
Basic Shares | 28,382 | 26,924 | 28,165 | 27,431 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.72 |
2024-09-30 | -$1.14 |
2024-06-30 | -$1.71 |
2024-03-31 | -$1.64 |
